Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $15.33 -1.90 (-11.03%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Neoleukin Therapeutics Stock Price Performance 5 Day Performance-55.58%1 Month Performance-70.89%3 Month Performance-57.23%6 Month Performance-54.93%Year-To-Date Performance-20.90%1 Year Performance+18.29% Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. NLTX Stock Chart for Thursday, November, 21, 2024 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$19.82$17.23-13.07%$20.99$17.011.23 million shs$161.93 million11/19/2024$3.49$19.82+467.91%$23.79$18.942.00 million shs$186.27 million11/18/2024$34.52$3.49-89.89%$3.59$3.42113,100 shs$32.80 million11/15/2024$39.20$39.20$43.24$38.97610,721 shs$368.40 million11/14/2024$40.00$39.20-2.00%$43.24$38.97610,658 shs$368.40 million11/13/2024$71.53$40.00-44.08%$49.37$35.601.99 million shs$375.92 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$68.21$71.53+4.87%$74.49$69.49425,376 shs$672.24 million11/11/2024$68.21$68.21$71.60$66.60180,962 shs$641.04 million11/08/2024$69.50$68.21-1.86%$71.60$66.60180,961 shs$641.04 million11/07/2024$64.40$69.50+7.92%$70.80$62.84330,422 shs$653.16 million11/06/2024$66.00$64.40-2.42%$65.64$55.88337,506 shs$605.23 million11/05/2024$46.07$66.00+43.26%$73.59$55.00962,458 shs$620.27 million11/04/2024$46.07$46.07$46.23$44.4791,503 shs$432.97 million11/01/2024$43.74$46.07+5.33%$46.23$44.4791,502 shs$432.97 million10/31/2024$43.74$43.74$46.01$43.5858,123 shs$411.07 million10/30/2024$45.15$43.74-3.12%$46.01$43.5858,123 shs$411.07 million10/29/2024$48.37$45.15-6.66%$46.94$44.4979,698 shs$424.32 million10/28/2024$48.37$48.37$50.85$47.7680,712 shs$454.58 million10/25/2024$48.20$48.37+0.35%$50.85$47.7680,706 shs$454.58 million10/24/2024$49.97$48.20-3.54%$49.38$47.67112,745 shs$452.98 million10/23/2024$49.97$49.97$52.68$48.00119,442 shs$469.62 million10/22/2024$52.66$49.97-5.11%$52.68$48.00118,458 shs$469.62 million10/21/2024$54.40$52.66-3.20%$54.64$52.30118,390 shs$494.90 million Related Companies XBiotech Stock Price Chart Annexon Stock Price Chart Humacyte Stock Price Chart Corvus Pharmaceuticals Stock Price Chart ABIVAX Société Anonyme Stock Price Chart Astria Therapeutics Stock Price Chart Sana Biotechnology Stock Price Chart Organogenesis Stock Price Chart Monte Rosa Therapeutics Stock Price Chart IGM Biosciences Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
